Enabling Better Care for Patients, Providers, Health Systems and Payors
Four out of five kidney failures come by surprise. Until now, identifying diabetic kidney disease patients most at risk has been a challenge. KidneyIntelX™ delivers critical and timely information to assess the risk of progressive kidney function decline in patients with type 2 diabetes – to optimize care and promote better outcomes.
First in Early Rapid Kidney Function Decline Prediction
KidneyIntelX is the only clinical diagnostic tool available that assesses the risk of progressive kidney function decline in CKD patients with type 2 diabetes.
AI-driven insights provide a personalized patient risk score, allowing physicians to improve monitoring and ongoing treatment.